Literature DB >> 6607791

Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.

A M Nouri, G S Panayi, S M Goodman.   

Abstract

Synovial fluids from patients with rheumatoid arthritis (13 cases), ankylosing spondylitis (six), psoriatic arthritis (two), osteoarthritis (three) and rubella arthritis (four) contain interleukin-1 (Il-1) activity as measured in the CH3/He mouse thymocyte assay. That this activity is Il-1 was shown by: (i) the time course of thymocyte stimulation; (ii) failure of PHA blast cells to absorb out the activity; (iii) molecular weight of 15,000-20,000 daltons, and (iv) ability to stimulate prostaglandin E2 production from synovial cells. These results indicate that IL-1 is an important mediator in the inflammatory pathway of different types of joint disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607791      PMCID: PMC1535803     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.

Authors:  S B Mizel; J J Oppenheim; D L Rosentreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Association of a low molecular weight helper factor(s) with thymocyte proliferative activity.

Authors:  W J Koopman; J J Farrar; J J Oppenheim; J Fuller-Bonar; S Dougherty
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

3.  "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation.

Authors:  D C Dumonde; R A Wolstencroft; G S Panayi; M Matthew; J Morley; W T Howson
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

4.  Purification of a factor from human blood monocyte-macrophages which stimulates the production of collagenase and prostaglandin E2 by cells cultured from rheumatoid synovial tissues.

Authors:  J M Dayer; M L Stephenson; E Schmidt; W Karge; S M Krane
Journal:  FEBS Lett       Date:  1981-02-23       Impact factor: 4.124

5.  Studies on the role of lymphocyte-activating factor (Interleukin 1) in antigen-induced lymph node lymphocyte proliferation.

Authors:  S B Mizel; A Ben-Zvi
Journal:  Cell Immunol       Date:  1980-09-01       Impact factor: 4.868

6.  The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen.

Authors:  M B Sztein; S N Vogel; J D Sipe; P A Murphy; S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  Cell Immunol       Date:  1981-09-01       Impact factor: 4.868

7.  Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation.

Authors:  H E Jasin; J T Dingle
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

8.  Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis.

Authors:  A Fontana; H Hengartner; E Weber; K Fehr; P J Grob; G Cohen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

9.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells.

Authors:  J M Dayer; D R Robinson; S M Krane
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  50 in total

Review 1.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

2.  Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay-inhibiting factors.

Authors:  J B Smith; M H Bocchieri; L Sherbin-Allen; M Borofsky; J L Abruzzo
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Stimulation of rheumatoid synovial and blood T cells and lines by synovial fluid and interleukin-2: characterization of clones and recognition of a co-stimulatory effect.

Authors:  N Hain; S Alsalameh; W M Bertling; J R Kalden; G R Burmester
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

4.  Polymorphisms for interleukin-1 beta (IL-1 beta)-511 promoter, IL-1 beta exon 5, and IL-1 receptor antagonist: nonassociation with endometriosis.

Authors:  Y Y Hsieh; C C Chang; F J Tsai; J Y Wu; Y R Shi; H D Tsai; C H Tsai
Journal:  J Assist Reprod Genet       Date:  2001-09       Impact factor: 3.412

5.  Interleukin-1, -6, and -8 levels in juvenile chronic arthritis.

Authors:  S Ozen; U Saatci; A Bakkaloglu; O Ozdemir; N Besbas; S Kirazli; S Ozdemir
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

Review 6.  The roles of catabolic factors in the development of osteoarthritis.

Authors:  Dominick J Blasioli; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2013-12-11       Impact factor: 6.389

7.  Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1.

Authors:  S J Hopkins; M Humphreys; M I Jayson
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

8.  Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

Authors:  C P Maury; L C Andersson; A M Teppo; S Partanen; E Juvonen
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

9.  Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line.

Authors:  R al-Daccak; K Mehindate; J Hébert; L Rink; S Mecheri; W Mourad
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts.

Authors:  R C Borghaei; P L Rawlings; E Mochan
Journal:  Arthritis Rheum       Date:  1998-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.